Good point, ACAD initiated the Phase 3 CLARITY trials for MDD three months ago.From anecdotal evidence, I strongly believe that MDD will alone make Pima a blockbuster tx. Getting AD Psychosis added to the label would be 'gravy'. www.acadia-pharm.com/pipeline/pimavanserin-major-depressive-disorder/ Pimavanserin β Major Depressive Disorder